RadNet EBIT 2010-2024 | RDNT

RadNet EBIT for the quarter ending September 30, 2024 was $0.034B, a 21.59% decline year-over-year.

  • RadNet 2023 EBIT was 0.099B, a 112.88% increase from 2022.
  • RadNet 2022 EBIT was 0.046B, a 43.84% decline from 2021.
  • RadNet 2021 EBIT was 0.083B, a 131.35% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

RadNet EBIT 2010-2024 | RDNT

  • RadNet 2023 EBIT was 0.099B, a 112.88% increase from 2022.
  • RadNet 2022 EBIT was 0.046B, a 43.84% decline from 2021.
  • RadNet 2021 EBIT was 0.083B, a 131.35% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$19.5B
Quest Diagnostics (DGX)$18B
DaVita (DVA)$12.9B
Encompass Health (EHC)$10B
Chemed (CHE)$8.2B
Elanco Animal Health (ELAN)$6.6B
Option Care Health (OPCH)$3.7B
Amedisys (AMED)$2.9B
LifeStance Health (LFST)$2.8B
Astrana Health (ASTH)$2.3B
Addus HomeCare (ADUS)$2.2B
U.S Physical Therapy (USPH)$1.4B
Aveanna Healthcare Holdings (AVAH)$1.1B
Pennant (PNTG)$1.1B
Atai Life Sciences (ATAI)$290M
Daxor (DXR)$43M
MEDIROM Healthcare Technologies (MRM)$15M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$8M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M